Oops! We couldn’t find any results...
Ontario Brain Institute, Epilepsy Ottawa, Neureka® Partne...
·
Feb 15, 2023
This study is remarkably impactful, showing that digital tools like Neureka can empower people living with epilepsy, and ...
Problem
Today’s epilepsy
care lacks data...
For many people with epilepsy, getting on the right treatment is a painfully slow process. It can be overwhelming to track seizures, medications, side effects, and sleep, and share accurate information with doctors. This all adds up to poor treatment decisions and long patient journeys toward seizure freedom.
Infrequent appointments, 30+ days between visits
Limited, inaccurate data leads to long treatment journeys
No at-home monitoring of sleep risk, including Sudden Unexpected Death in Epilepsy (SUDEP)
—
...and there isn’t enough data to
solve the mystery of SUDEP:
—
Sudden Unexpected Death in Epilepsy (SUDEP) is when an otherwise healthy person with epilepsy dies suddenly without warning, and no reason for death is found. SUDEP deaths typically occur during sleep.
SUDEP claims the lives of over 1 in 1,000 people with epilepsy every year. Its cause is currently unknown, and it remains poorly understood because there isn’t enough data to solve the mystery of SUDEP.
|
|---|
Even if you're not aware of it, you probably know someone with epilepsy. Epilepsy is the 4th most common neurological condition worldwide and affects 1 in 26 Americans in their lifetime.
SUDEP claims the lives of over 65,000 people worldwide every year of all ages, nationalities, and genders. SUDEP often strikes without warning, leaving a devastating impact on families and loved ones left behind. |
Solution
Neureka® reimagines epilepsy care
Neureka® provides AI-powered wearables for on-demand, 24/7 epilepsy care—from the comfort of home.
Patients & their loved ones no longer have to struggle with long wait times between appointments and a lack of understanding of their treatment progress.
With Neureka®, patients can connect with their care teams and review their health data wherever, whenever. Their doctors are empowered with data to help make treatment decisions with more confidence.
This data can also be used to help researchers solve the mystery of SUDEP, in the hope of developing new life-saving interventions.
Product
Meet Neureka®
Neureka® makes it easy for patients
to manage all aspects of their epilepsy,
24/7, with all their health data at their fingertips.
—
Neureka® sends instant alerts to improve medication adherence & deliver preventative care.
Patients can easily track seizures, get medication reminders, log side effects, send caregiver help alerts, record smart voice memos, and more.
—
Neureka® Sleep wearables offer peace of mind for epilepsy patients during sleep, when SUDEP can strike.
Neureka® Sleep monitors health metrics at night, with instant caregiver alerts if sudden changes are detected. Insightful sleep summaries help people with epilepsy better manage their sleep and share critical information with their doctors.
How it works
Data-driven care, 24/7
Neureka® improves outcomes with on-demand care & instant caregiver alerts.
Neureka® wearables collect 24/7 health and seizure data, while patients can conveniently manage their medications, side effects, sleep quality, and more using Neureka® apps.
All this critical data is seamlessly shared in real-time with patients' care teams.
Neureka® helps doctors make data-driven treatment plans, while instant caregiver alerts improve patient safety and wellbeing.
Data from Neureka® also empowers a global community of researchers, clinicians, and mission-driven companies to uncover the cause of SUDEP and accelerate the development of new life-saving interventions.
Traction
10+ years of R&D
coming to market
Neureka® has accelerating market traction, with partnering US epilepsy centers and B2C revenue.
We have proud partnerships with leading institutions across the United States and Canada.
Customers
Developed with the epilepsy community, for the epilepsy community
Patient testimonials
Partner testimonials
Business model
Data-centric
epilepsy care at scale
Neureka® targets $700M*+ in revenues, beginning with B2C sales, then scaling B2B with insurance & pharma.
- B2C: Neureka® Sleep & automated seizure-detection devices sold directly to families. Offers at-home 24/7 monitoring
B2B: AI insights for health systems, to prioritize patients at highest risk of SUDEP
B2B: Providing pharma & insurance with real-world data (RWD) to improve outcomes at lower cost
Market
$21B TAM
Neureka® targets a $21B TAM for epilepsy alone, with a $700M+ Serviceable Obtainable Market of refractory epilepsy patients in the US.
Competition
Unprecedented data collection with
FDA-cleared tech
Neureka® collects & analyzes an unprecedented amount of data using FDA-cleared seizure-detection & alerting wearables for at-home use. Neureka® accurately detects tonic-clonic seizures (TCS), which can lead to SUDEP.
Other seizure-detection wearables simply track changes in wrist motion that can indicate convulsive seizures, making them inconvenient and prone to false alerts.
Neureka® is different: our proprietary seizure-detection devices measure surface electromyography (sEMG) signals from biceps muscles, and are clinically validated with up to 100% accuracy.
Even better? Neureka® offers patients unmatched protection and peace of mind from SUDEP risk. Neureka® combines multiple modes of at-home AI-powered monitoring—including video, audio, sleep metrics, and medication data—to empower patients on a safer, faster journey to seizure freedom.
Vision and strategy
The future of epilepsy care
Neureka® collects an unprecedented amount of data and real-time insights. As Neureka® gains traction, our large datasets can be analyzed to someday solve the mystery of SUDEP and develop new life-saving interventions. The future of epilepsy care is data-centric at-home care, to alert patients and improve their safety & quality of life.
What's next?
The Neureka® market frontier
Neureka® is an extensible platform for multiple neurological conditions, including sleep disorders, migraine, and more.
Impact
Invest in a company that actually moves the needle
Neureka® has demonstrated lasting scalable change, with a potential to improve care for 200,000 patients and deliver $2.5B of healthcare cost savings in the US.
Third-party certified by ImpactableX
Funding
$4.5M raised
Founders
A passionate
team on a mission
We're leading a movement to raise the quality of life of people living with epilepsy, and improve treatment outcomes with more personalized care.
We are driven to deliver “Neureka®!” moments to as many people as possible: that moment when people are able to focus on living their best life, without being defined by their condition.
We’re a passionate team of patient advocates, medical professionals, data analysts, and entrepreneurs—with deep expertise in digital health.
